Business Description
Suzhou Basecare Medical Corp Ltd
ISIN : CNE100004BC1
Share Class Description:
HKSE:02170: Class HTotal Employee Number:
407Compare
Compare
Traded in other countries / regions
02170.Hong Kong IPO Date
2021-02-08Description
Suzhou Basecare Medical Corp Ltd is a medical device company based in China, operating in the field of assisted reproduction. It is engaged in the research, development, and provision of medical products and related software in the field of reproductive health, to enable more families to have children. The Group's product portfolio comprises Gems Sperm Wash Gradient Set, Gems Fertilisation Medium, Gavi Instrument, Geri Incubator, Cryostorage System, PGT-A kit, Self sperm testing device, Sperm quality analyser, Genie sequencer, and others. It generates maximum revenue from the sale of testing kits. The Group's reportable segments are: the PRC, which derives maximum revenue, and Australia. Geographically, it operates in the PRC, Europe, Asia (excluding the PRC), and other regions.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.29 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | -1.61 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.44 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.9 | |||||
3-Year EBITDA Growth Rate | -11.6 | |||||
3-Year EPS without NRI Growth Rate | -13.9 | |||||
3-Year FCF Growth Rate | 7.6 | |||||
3-Year Book Growth Rate | -16.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 47.33 | |||||
9-Day RSI | 50.32 | |||||
14-Day RSI | 48.96 | |||||
3-1 Month Momentum % | -24.87 | |||||
6-1 Month Momentum % | -26.04 | |||||
12-1 Month Momentum % | -55.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.98 | |||||
Quick Ratio | 3.45 | |||||
Cash Ratio | 2.33 | |||||
Days Inventory | 348.54 | |||||
Days Sales Outstanding | 260.16 | |||||
Days Payable | 131.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -5.07 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 52.99 | |||||
Operating Margin % | -90.6 | |||||
Net Margin % | -95.68 | |||||
EBITDA Margin % | -91.67 | |||||
FCF Margin % | -108.46 | |||||
OCF Margin % | -71.84 | |||||
ROE % | -21.77 | |||||
ROA % | -14.46 | |||||
ROIC % | -24.67 | |||||
3-Year ROIIC % | 2.34 | |||||
ROC (Joel Greenblatt) % | -39.73 | |||||
ROCE % | -15.82 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.49 | |||||
PB Ratio | 0.37 | |||||
Price-to-Tangible-Book | 0.5 | |||||
EV-to-EBIT | -1.14 | |||||
EV-to-EBITDA | -1.14 | |||||
EV-to-Revenue | 1.04 | |||||
EV-to-FCF | -0.96 | |||||
Price-to-GF-Value | 0.48 | |||||
| Price-to-Net-Current-Asset-Value | 1.41 | |||||
Earnings Yield (Greenblatt) % | -87.72 | |||||
FCF Yield % | -72.65 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Suzhou Basecare Medical Corp Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 256.517 | ||
| EPS (TTM) (HK$) | -0.879 | ||
| Beta | 0.7763 | ||
| 3-Year Sharpe Ratio | -0.4 | ||
| 3-Year Sortino Ratio | -0.65 | ||
| Volatility % | 55.55 | ||
| 14-Day RSI | 48.96 | ||
| 14-Day ATR (HK$) | 0.042969 | ||
| 20-Day SMA (HK$) | 1.3885 | ||
| 12-1 Month Momentum % | -55.49 | ||
| 52-Week Range (HK$) | 1.23 - 4.36 | ||
| Shares Outstanding (Mil) | 273.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Suzhou Basecare Medical Corp Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Suzhou Basecare Medical Corp Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Suzhou Basecare Medical Corp Ltd Frequently Asked Questions
What is Suzhou Basecare Medical Corp Ltd(HKSE:02170)'s stock price today?
The current price of HKSE:02170 is HK$1.40. The 52 week high of HKSE:02170 is HK$4.36 and 52 week low is HK$1.23.
When is next earnings date of Suzhou Basecare Medical Corp Ltd(HKSE:02170)?
The next earnings date of Suzhou Basecare Medical Corp Ltd(HKSE:02170) is .
Does Suzhou Basecare Medical Corp Ltd(HKSE:02170) pay dividends? If so, how much?
Suzhou Basecare Medical Corp Ltd(HKSE:02170) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Suzhou Basecare Medical Corp Ltd
No articles.